Cytokine |
Indication |
Skin adverse reactions |
IFN-α |
Leukemia, Kaposi's sarcoma, hepatoma, malignant tumor, AIDS, hepatitis C and B, Behcet disease, hemangiomas, keloids, actinic keratosis, cutaneous T-cell lymphoma, keloids, advanced melanoma |
Local redness, pain, swelling, induration, necrosis or purulent actions at the injection sites, flu-like symptom, urticaria, pigmentation, multiple fixed drug eruption, erythema dermatitis, eczematous reaction, bullous lesions, cutaneous vasculitis, sarcoidosis-like lesion, alopecia areata, hair color change, lichen planus, lichenoid eruptions, granuloma, vitiligo, raynaud's phenomenon, xerostomia, livedo reticularis, seborrheic dermatitis, angioedema, aphthous ulcer, rehumatiod and lupus-like symptoms, induce or aggravate autoimmune disorders (such as psoriasis, eosinophilic fascitis, anasarca, paraneoplastic pemphigus, herpes labialis, and systemic lupus erythematosus) [4,6,8,10,11,16,32,69,75-79] |
IFN-β |
Multiple sclerosis |
Local inflammatory reactions, nodule, necrosis and ulcers at the injection sites, flu-like symptom, subacute cutaneous lupus erythematous, severe urticaria, vasculitic-like lesion, sarcoidosis, allergic contact dermatitis, aggravate autoimmune disorders (such as psoriasis) [25,30,80-82] |
IFN-γ |
Chronic granuloma, genital warts, Rheumatoid arthritis, nsitization dermatitis, malignant tumor, infection viral, atopic dermatitis |
Local redness, pain and swelling, erythema nodosum leprosum, flu-like symptoms, SLE-like symptom, aggravate the inflammation of eczema [32,34,83] |
G-CSF |
Granulocytopenia result from autologous bone marrow transplantation and chemotherapy, AIDS, aplastic anemia, leukemia |
Nodule at the injection sites, exanthematic eruption, severe toxic epidermal necrolysis, leukocytoclastic vasculitis, pseudotumor hyperplasia, neutrophils sweat duct inflammation, Sweet's syndrome, bullous pyoderma gangrenosum, cutaneous vasculitis or follicultitis [36,41,43,72,84-88] |
GM-CSF |
Granulocytopenia result from autologous bone marrow transplantation and chemotherapy, AIDS, aplastic anemia, wound healing, cutaneous T-cell lymphoma, melanoma, chronic ulcers |
Urticaria, edema, local or widespread erythematous dermatitis-like skin lesion, pustules or necrotizing vasculitis at the injection sites, aggravate the primary lesion, such as Sweet's syndrome, bullous pyoderma gangrenosum, psoriasis, psoriatic arthritis, cutaneous vasculitis [32,41,71,72,81] |
EPO |
Anemia induced by chronic renal failure, malignant tumor or chemotherapy |
Generalized eczema, exfoliative dermatitis [45,46] |
IL-1 |
Bone marrow depression caused by chemoradiation, malignant tumor |
Flu-like symptom, erythematous dermatitis-like skin lesion, aggravate the primary lesion [47] |
IL-2 |
Genital warts, sensitization dermatitis, malignant tumor, infection viral |
Flu-like symptom, exanthematous dermatitis, severe toxic epidermal necrolysis, vascular leak syndrome, generalized edema, angioneurotic edema, urticaria, aggravate the primary lesion (such as psoriasis, eczema) or increase the risk of drug-induced hypersensitivity reactions [32,50,52,63,89-91] |
IL-3 |
Marrow failure, aleukia, autologous bone marrow transplantation, immunoadjuvants |
Flu-like symptom, minor erythematous reactions at the injection sites, urticaria [56] |
IL-6 |
Immunodeficiency, malignant tumor, immunoadjuvants |
Moderate injection-site reactions, maculopapular erythema, papulae, scale [58,72] |
TNF-α |
Malignant tumor, leukemia, bone marrow transplantation, cut down cholesterol |
Flu-like symptom, local reactions [59-61]. |
|